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M

ore than 50,000 active-duty
U.S. Air Force (USAF) service members, retirees, and
family members with diabetes receive
care at more than 50 military treatment facilities (MTFs) throughout the
continental United States.1 Although
many of these patients are referred
to civilian network diabetes specialists because of a scarcity of military
endocrinologists, most are managed
by USAF primary care providers
(PCPs). In an effort to assist PCPs in
managing complex diabetes cases,
a team from the USAF Diabetes
Center of Excellence (DCOE) in San
Antonio, Tex., adopted the Extension
for Community Healthcare Outcomes
(ECHO) model of care.
Research Design and Methods
The ECHO model of health care
delivery was developed and implemented originally by Dr. Sanjeev
Aurora and his team at the University
of New Mexico2 to treat underserved
patient populations with hepatitis C.
The model uses technology, specifically video teleconferencing, to
provide support to PCPs in remote
areas who may lack the experience,
knowledge, or confidence needed
to manage this complex condition.
Results demonstrated that patients
treated remotely through ECHO
experienced similar clinical improvement with fewer adverse events
than those treated at the university
specialty clinic. The University of
New Mexico has adapted the ECHO
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model for ~ 20 other chronic illnesses,
including diabetes.
After training with the New
Mexico team, DCOE endocrinologists and support personnel adapted
the ECHO model to address the
unique needs of military PCPs and
their patients with diabetes. The
USAF ECHO initiative was designed
such that sessions, open to all military medical staff (including, but not
limited to, specialty care providers,
midlevel providers, nursing staff,
pharmacists, and nutritional medicine professionals), were transmitted
via video and telephone conferencing
systems twice monthly. The consulting team from the DCOE consisted
of endocrinologists, endocrinology
fellows, certified diabetes educators
(registered dietitians and registered
nurses), and behavioral specialists.
An electronic case referral form,
including information about medical
and psychosocial history, laboratory
data, and current treatment plan,
was designed and distributed to all
participants to standardize case submissions. At each session, cases were
presented by the submitting provider
and discussed among participants,
including the submitting provider,
DCOE team members, and other
medical professionals in conference
who wished to contribute.
Each session also included a
didactic presentation on a relevant
diabetes-related topic provided by a
subject matter expert. Topic suggestions were solicited from prospective
participants. Continuing medical

education credit was offered as an
incentive to all participants who
attended sessions.
The initial aim of the project
was to better equip PCPs with the
tools (knowledge, support, and
confidence) to better manage their
complex diabetes patients. The
DCOE team elected to track provider outcomes rather than clinical
outcomes (such as measures of glycemic control) because multiple factors
influence clinical outcomes, many of
which cannot be isolated from the
impact of the ECHO intervention.
In addition, the concurrent launch
of several other USAF diabetes
initiatives further compounded the
problem of being able to establish
the specific effect of ECHO on clinical outcomes.
After each session, participants
were asked to complete a feedback
questionnaire, through which
respondents rated their agreement
to statements regarding their preand post-session knowledge and
confidence levels, as well as their
intention to change their practice.
The questionnaire used a Likert
scale in which 0 indicated strong
disagreement with a statement and
5 indicated strong agreement with
a statement. To isolate the effects
of the intervention on the target
population of PCPs from total participants, DCOE planners included
a section in which respondents
selected their appropriate medical
background. A paired t-test was
used to determine the significance of
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Table 1. Participant Feedback*
Questionnaire Items
(Participants were asked to rate their degree of agreement with each statement.)

All
Participants

PCPs
Only

“I had sufficient knowledge of the discussion topic before the ECHO presentation/session.”

3.62

3.6

“I have sufficient knowledge of the discussion topic after the ECHO presentation/session.”

4.5

4.42

< 0.001

< 0.001

“I felt confident with regard to the treatment of complex diabetes patients before this
ECHO session.”

3.52

3.61

“I feel confident with regards to the treatment of complex diabetes patients after this
ECHO session.”

4.24

4.39

< 0.001

< 0.001

“I am likely to make changes to my treatment practice for patients with diabetes based on what
I learned in the ECHO session today.”

4.08

4.29

Respondents who rated intent to change practice at 3 (slightly agree) or higher (%)

94.9

96.8

Respondents who rated intent to change practice at 5 (strongly agree) (%)

41.8

45.2

98

31

23.4

27.9

Perceived knowledge

Significance value from paired t-test (P)
Confidence

Significance value from paired t-test (P)
Intention to change current practice

Total responses from 20 sessions (n)
Average response rate (%)

*Average feedback for all sessions in 2012.
Likert scale key: 0, strongly disagree; 1, moderately disagree; 2, slightly disagree; 3, slightly agree; 4, moderately agree; and
5, strongly agree.
differences between pre- and postsession scores.
Results
The first session was held on 13
January 2012; 20 ECHO sessions were
conducted throughout that year. Over
the course of the year, 145 participants
registered for ECHO from 20 separate
MTFs; however, 28 participants (19%)
did not attend any sessions, primarily because of schedule constraints.
Participants included 50 PCPs (12 of
these identified themselves as midlevel providers), as well as primary
care residents, endocrinologists, registered nurses, dietitians, pharmacists,
and others. The average attendance
was 25 participants per session.
Participants submitted 17 cases for
discussion in 2012; these were supplemented with 20 DCOE clinic cases for

CLINICAL DIABETES • Volume 32, Number 2, 2014

a total of 37 cases addressed over the
course of the year.
Outcome data (Table 1) showed
the overall response rate was 23.4%
for all participants and 27.9% for
PCPs. The average self-score for
perceived level of knowledge before
sessions was 3.62 for all respondents
and 3.60 for PCPs. The average
self-score for perceived level of
knowledge after sessions was 4.50 for
all respondents and 4.42 for PCPs.
For both groups, this increase in
perceived diabetes knowledge was
statistically significant (P < 0.001 and
P < 0.001, respectively). The average
self-score for personal confidence
level with regard to treating complex
diabetes patients before sessions
was 3.52 for all respondents and 3.61
for PCPs. The average self-score for
personal confidence level with regard

to treating complex diabetes patients
after sessions was 4.24 for all respondents and 4.39 for PCPs. For both
groups, this increase in personal
confidence level was statistically
significant (P < 0.001 and P < 0.001,
respectively).
Nearly all (94.9%) respondents
indicated that they were at least
somewhat likely to alter their current diabetes management practices
based on what they had learned
at the session. A similar proportion of PCPs (96.8%) agreed with
the statement, “I am likely to make
changes to my treatment practice
for patients with diabetes based on
what I learned in the ECHO session
today” at a level of 3 (“somewhat
agree”) or higher. Nearly half of
the PCPs (45.2%) agreed with this
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statement at the maximum level of
5 (“strongly agree”).
Discussion and Conclusions
The ECHO Initiative, like other
current USAF Medical Services
initiatives, fits the patient-centered
medical home model of care by
supporting the PCP team’s ability to
provide comprehensive, high-quality
care. Data collected from participant
feedback indicated that the ECHO
intervention resulted in a significant
positive change in perceived diabetes
knowledge and personal confidence
levels, as well as intention to modify
practice, among PCPs and other medical personnel in the Military Health
Services. Surprisingly, a substantial
number of participants were from
outside the original target population (PCPs), and, like the PCPs, these
participants found ECHO sessions
to be educational, confidence build-
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ing, and likely to result in a change in
personal practice.
The implications of these results
include the potential to successfully
manage complex diabetes patients
at the primary care level and reduce
referrals to the private sector.
Treating more patients at the primary care level will lead to improved
continuity of care, improved patient
access, and significant cost savings.
In the future, the DCOE plans to
examine the effects of ECHO on
clinical outcome trends and referral
rates. The USAF is also expanding
the ECHO initiative to include other
specialty care areas.
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Free Resource
for your patients
newly diagnosed
with type 2
diabetes.
Where Do I Begin? offers information
they need to know at diagnosis.
Order free copies of Where Do I
Begin? for your patients.

Visit diabetes.org/atdx
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